Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply
Aliment Pharmacol Ther
.
2019 Jun;49(12):1529.
doi: 10.1111/apt.15283.
Authors
Siddharth Singh
1
2
,
Vipul Jairath
3
4
,
Stitt Lw
5
,
Zou G
3
5
,
Khanna R
4
5
,
Dulai Ps
1
,
Sandborn Wj
1
,
Feagan Bg
3
4
5
Affiliations
1
Division of Gastroenterology, University of California San Diego, La Jolla, California, Research Institute, London, Ontario, Canada.
2
Division of Biomedical Informatics, University of California San Diego, La Jolla, California.
3
Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
4
Department of Medicine, Division of Gastroenterology, University Hospital, Ontario, Canada.
5
Robarts Research Institute, London, Ontario, Canada.
PMID:
31134649
PMCID:
PMC6581562
DOI:
10.1111/apt.15283
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Aged
Crohn Disease*
Humans
Immunosuppression Therapy
Immunosuppressive Agents
Substances
Immunosuppressive Agents
Grants and funding
K23 DK117058/DK/NIDDK NIH HHS/United States